Strides Pharma Science announced that Puneet Kumar Malik, Senior Management Personnel of the Company has desired to relinquish his position w.e.f. close of business hours on 31 January 2026 to pursue other opportunity within the Aditya Birla Group.Powered by Capital Market - Live News

Strides Pharma Science announced that Surabhi Loshali, Group CHRO of the Company, has resigned from Strides to pursue her personal and professional aspirations. Her last working day with Strides shall be closing business hours of 02 January 2026.Powered by Capital Market - Live News

Net profit of Strides Pharma Science rose 77.52% to Rs 127.53 crore in the quarter ended September 2025 as against Rs 71.84 crore during the previous quarter ended September 2024. Sales rose 4.62% to Rs 1220.83 crore in the quarter ended September 2025 as against Rs 1166.93 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales1220.831166.93 5 OPM %18.8815.76 - PBDT211.53138.53 53 PBT161.8990.08 80 NP127.5371.84 78 Powered by Capital Market - Live News

Strides Pharma Science will hold a meeting of the Board of Directors of the Company on 31 October 2025.Powered by Capital Market - Live News

Strides Pharma Science sales rose 6.20% to Rs 1119.74 crore in the quarter ended June 2025 as against Rs 1054.34 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales1119.741054.34 6 OPM %19.4817.87 - PBDT179.30128.64 39 PBT130.4182.12 59 NP99.613351.47 -97 Powered by Capital Market - Live News